Alzheimer's drug looks promising

Comment on this story


iol scitehc july 18 Gammagard

AP

Boxes of Gammagard, a treatement that is being tested for Alzheimer's disease.

For the first time, researchers are reporting that a treatment might help stabilise Alzheimer's disease for as much as three years, but the evidence is weak and only in four patients.

The treatment is Gammagard, made by Baxter International. Doctors say four patients who received the highest dose in early testing showed no decline on memory and cognition tests three years later. A bigger, more rigorous study of the treatment will give results within a year.

The drug is a collection of antibodies from pooled blood donations given as infusions every two weeks. These antibodies may help clear the sticky plaque that clogs patients' brains.

The results were discussed on Tuesday at an Alzheimer's conference in Vancouver, British Columbia. - Sapa-AP

Hungry for more scitech news? Sign up for our daily newsletter


sign up
 
 

Comment Guidelines



  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

     

Join us on

IOL-Social networks IOL-Social networks IOL-Social networks IOL-Social networks